SEARCH

SEARCH BY CITATION

References

  • Alexander NDE, Cousens SN, Yahaya H, Abiose A & Jones BR (1993) Ivermectin dose assessment without weighing scales. Bulletin of the World Health Organization 71, 361366.
  • Alleman M, Twum-Danso NAY & Thylefors B. (2006) The Mectizan Donation Program – highlights from 2005. Filaria Journal 5, 11.
  • Amazigo UV, Obono DM, Dadzie KY et al. (2002) Monitoring community-directed treatment programmes for sustainability: lessons from the African Program for Onchocerciasis Control. Annals of Tropical Medicine and Parasitology 96 (Suppl. 1), S75S92.
  • Anonymous (1991) Ivermectin: possible neurotoxicity. WHO Drug Information 5.
  • APOC/WHO (2006) APOC and the Millennium Development Goals. APOC, Burkina Faso.
  • Awadzi K, Dadzie KY, Schulz-Key H, Haddock DRW, Gilles HM & Aziz AM (1985) The chemotherapy of onchocerciasis. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Annals of Tropical Medicine and Parasitology, 79, 6378.
  • Aziz MA, Diallo S, Diop IM, Lariviere M & Porta M (1982) Efficacy and tolerance of ivermectin in human onchocerciasis. The Lancet 2, 171173.
  • Boussinesq M (2006) Loiasis. Annals of Tropical Medicine and Parasitology 100, 715731.
  • Brown KR (1998) Changes in the use profile of Mectizan 1987–1997. Annals of Tropical Medicine and Parasitology 92 (Suppl. 1) S61S64.
  • Burnham G & Mebrahtu T (2004) The delivery of ivermectin (Mectizan). Tropical Medicine and International Health 9 (Suppl.), pp A26A44
  • Chippaux JP, Gardon-Wendel N, Ernould J-C & Gardon J (1995) Comparaison entre differentes methods de depistage des grosseses au cours de traitements par ivermectine a large echelle au Cameroun. Bulletin de la Societe de Pathologie Exotique 3, 129133.
  • Colatrella B (2003) The Mectizan Donation Program – successful collaboration between the public and private sector. Drug Donations 33, 2728.
  • Collins K (2004) Profitable gifts – a history of the Merck Mectizan Donation Program and its implications for international health. Perspectives in Biology and Medicine 47, 100109.
  • Cupp EW & Cupp MS (2005) Impact of ivermectin community-level treatments on the elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. American Journal of Tropical Medicine and Hygiene 73, 11591161.
  • De Sole G, Remme J, Awadzi K et al. (1989) Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bulletin of the World Health Organization, 67, 707719.
  • Drameh PS, Richards FO, Derstine P, Cross C, Etya’ale DE & Kassalow JS (2002) Ten years of NGO action against river blindness. Trends in Parasitology 18, 37880.
  • Ducorps M, Gardon-Wendel N, Ranque S et al. (1995) Effets secondaires du traitement de la loase hypermicrofilaremique par l’ivermectine. Bulletin de la Societe de Pathologie Exotique 88, 105112.
  • Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue & Duke BO (2002) Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomized control trial. Lancet 360, 203210.
  • Gyapong JO, Chinbuah MA & Gyapong M (2003) Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis. Tropical Medicine & International Health 8, 10931101.
  • Haselow NJ, Akame J, Evini C & Akongo S (2003) Programmatic and communication issues in relation to serious adverse events following ivermectin treatment in areas co-endemic for Onchocerciasis and Loiasis. Filaria Journal 2, S2.
  • Hopkins DR, Richards F & Katabarwa M (2005) Whither onchocerciasis control in Africa? American Journal of Tropical Medicine and Hygiene 72, 1.
  • Mectizan Donation Program (2003) Report of a scientific working group on serious adverse events following mectizan treatment of onchocerciasis in Loa loa endemic areas. Filaria Journal 2,S2.
  • Ngoumou P & Walsh JF (1993) A Manual for Rapid Epidemiological Mapping of Onchocerciasis. TDR/TDE/ONCHO/93.4, WHO, Geneva.
  • Ngoumou P, Walsh JF & Mace JM (1994) A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Annals of Tropical Medicine and Parasitology 88, 463474.
  • Pacque M, Munoz B, Poetschke G, Foose J, Greene BM & Taylor HR (1990) Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution. Lancet 336, 14861489.
  • Peters DH & Phillips T (2004) Mectizan Donation Program: evaluation of a public–private partnership. Tropical Medicine and International Health 9, A4.
  • Sturchio JL & Colatrella BD (2002) Successful public-private partnerships in global health: lessons from the Mectizan Donation Program. In: Economics of Essential Medicines (ed. BGranville) Royal Institute of International Affairs, London, pp. 255274.
  • Taylor HR, Duke BOL & Munoz B (1992) The selection of communities for treatment of onchocerciasis with ivermectin. Tropical Medicine & Parasitology 43, 267270.
  • Thylefors B (2004) Eliminating onchocerciasis as a public health problem. Tropical Medicine & International Health 9, A1A3.
  • Thylefors B & Alleman M (2006) Towards the elimination of onchocerciasis. Annals of Tropical Medicine and Parasitology 100, 733746.
  • Tielsch JM & Beeche A (2004) Impact of ivermectin on illness and disability associated with onchocerciasis. Tropical Medicine and International Health 9, A45A56.
  • Twum-Danso NAY (2003) Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases. Filaria Journal 2, S3.
  • Twum-Danso NAY. (2004) Mass treatment of onchocerciasis with ivermectin: should people with epilepsy and/or growth-retardation syndromes be excluded? Annals of Tropical Medicine and Parasitology 98, 99114.
  • White AT, Newland HS, Taylor HR et al. (1987) Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis. Journal of Infectious Diseases 156, 463.
  • WHO (1991) Strategies for Invermectin Distribution through Primary Health Care Systems. WHO/PBR/91.24. WHO, Geneva.
  • WHO (1995) Onchocerciasis and Its Control; Report of a WHO Expert Committee on Onchocerciasis Control. TRS8. WHO, Geneva
  • WHO (2006) Preventive Chemotherapy in Human Helminthiasis. WHO, Geneva.
  • WHO/TDR (1996) Community-Directed Treatment with Ivermectin. TDR/AFR/RP/96.1. WHO, Geneva.
  • WHO/TDR (2000) Implementation and Sustainability of Community-Directed Treatment of Onchocerciasis with Ivermectin. TDR/IDE/RP/CDTI/00.1. WHO, Geneva.
  • WHO/TDR (2001) Rapid Assessment Procedures for Loiasis. TDR/IDE/RP/RAPL/01.1. WHO, Geneva.
  • Winnen M, Plaisier AP, Alley ES et al. (2002) Can ivermectin mass treatment eliminate onchocerciasis? Bulletin of the World Health Organization 80, 384390.